Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 May 23:37:e20250182.
doi: 10.62675/2965-2774.20250182. eCollection 2025.

Pulmonary artery pressure assessed by catheterization and its concordance with transthoracic echocardiographic estimates in patients with pulmonary arterial hypertension: experience of the Colombian Pulmonary Hypertension Network in a real-life study

Affiliations
Multicenter Study

Pulmonary artery pressure assessed by catheterization and its concordance with transthoracic echocardiographic estimates in patients with pulmonary arterial hypertension: experience of the Colombian Pulmonary Hypertension Network in a real-life study

Mauricio Orozco-Levi et al. Crit Care Sci. .

Abstract

Objective: To evaluate the correlation and concordance of pulmonary artery systolic pressure values measured via right heart catheterization and estimated via transthoracic echocardiography based on data from a multicenter cohort of patients with pulmonary hypertension in Colombia.

Methods: A retrospective study was conducted of patients with pulmonary hypertension classified into Groups 1 or 4 according to the definitions of the ESC/ERS-PH-2022 guidelines. Patients were obtained from the Colombian Pulmonary Hypertension Network (HAPredco) database.

Results: A total of 633 patients were identified and included in this study. Among these patients, 77.7% (n = 492) had complete data from transthoracic echocardiography at diagnosis, 58,3% (n = 369) had complete data from right heart catheterization at the time of diagnosis, and 264 (41.7%) had complete data from both tests at diagnosis, with a difference in days between them of 1 (84). The values of pulmonary artery systolic pressure estimated by transthoracic echocardiography and those obtained by right heart catheterization were significantly correlated (p < 0.001) in the entire population evaluated, as was the correlation assessed for those patients with a gap of ≤ 7 days (p = 0.0001) or ≤ 48 hours (p = 0.041) between the two examinations; however, these findings presented a low Spearman (0.32 for ≤ 7 days and 0.264 for ≤ 48 hours) and Lin´s correlation coefficient (0.32 for ≤ 7 days and 0.21 for ≤ 48 hours).

Conclusion: The pulmonary artery systolic pressure values estimated via transthoracic echocardiography and measured via right heart catheterization were significantly but weakly linearly correlated, with low concordance. These findings suggest interindividual variability between the pulmonary artery systolic pressure values obtained by the two methods, which may have clinical significance in follow-up and decision-making.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr. Orozco-Levi is the inventor of 14 medical devices, none of which are related to the present manuscript; he declares no relationship with the tobacco industry; he is the head of the EMICON group, which has received research grants from MINCIENCIAS-Colombia; he is codirector of the Colombian Network of Pulmonary Hypertension (HAPred.co); member of ASONEUMOCITO, ALAT, SEPAR and ATS Scientific Societies; and he has participated in advisory boards and received consulting and/or lecture fees from Bayer, Actelion/Janssen, Pint-Pharma, and Abbott. Dr. Conde has received sponsorship from GlaxoSmithKline, Actelion/Janssen Cilag, Pint Pharma, Ferrer International and Bayer for academic and consulting activities. Dr. Pacheco Gallego has nothing to disclose. Dr. Gómez-Palau has been a member of the Advisory Board and a speaker for Bayer and Janssen on PAH-related topics.

Figures

Figure 1
Figure 1. Risk assessment defines 1-year mortality in pulmonary arterial hypertension patients.
CF-WHO - World Health Organization functional class; 6MWT - 6-minute walk test; VO2 - oxygen consumption; VE/VCO2 - ratio of minute ventilation to carbon dioxide production; BNP - brain natriuretic peptide; NT-proBNP: N-terminal pro-brain natriuretic peptide; RA - right atrium; TAPSE - tricuspid annular plane systolic excursion; PASP - pulmonary arterial pressure; RAP - right atrial pressure; SVO2 - mixed venous blood oxygen saturation. Risk was defined as 1-year mortality.
Figure 2
Figure 2. Distribution of patients in Group 1 with pulmonary hypertension.
Figure 3
Figure 3. New York Heart Association functional classes.
Distribution of percentages of the study patients in each NYHA functional class. NYHA - New York Heart Association.
Figure 4
Figure 4. Diagram of diagnostic exams.
Diagram of patients with transthoracic echocardiography, right heart catheterization or both. RHC - right heart catheterization; TTE - transthoracic echocardiography.
Figure 5
Figure 5. Scatter plot of pulmonary pressures measured via a pulmonary artery catheter and estimations based on transthoracic echocardiography.
Scatter plot with the regression line for systolic blood pressure (mmHg) measured by right heart catheterization or estimated by transthoracic echocardiography in all patients. The colors represent the groups of patients defined according to the time difference (in days) between the two measurement techniques in each case, right heart catheterization and transthoracic echocardiography, with intervals of less than 2 days, 2–7 days or more than 7 days. The X-axis represents the gold standard of measurement expressed as the pressure measured during pulmonary artery catheterization. The Y axis represents the values estimated via transthoracic echocardiography. Both axes of the graph have the same value scale. The dashed diagonal represents the line of identity and makes it possible to show which values are identical between catheterization and transthoracic echocardiography. The values that are outside the identity line indicate that the agreement is less than 1. Those nonidentical values are distributed in four quadrants. Quadrant a represents the proportion of values that have been overestimated by transthoracic echocardiography. The values in quadrants b and c represent the high and low values, respectively, of both measurement methods that are not necessarily identical. Quadrant d shows pressure values that have been underestimated by transthoracic echocardiography. PAMP - pulmonary artery mean pressure; RHC - right heart catheterization.
Figure 6
Figure 6. Bland–Altman plot for systolic blood pressure (mmHg) measured by right heart catheterization and transthoracic echocardiography.
The red lines correspond to the confidence intervals for the difference vs. the mean of the pulmonary artery pressure variables measured by right heart catheterization and estimated via transthoracic echocardiography.
Figure 7
Figure 7. Heat plot for systolic pulmonary pressure measured by ultrasound and right heart catheterization, classified according to pulmonary vascular resistance.
Heat gradient of transthoracic echocardiography values plotted on the Y axis and right heart catheterization pressures plotted on the X axis, in which the cold colors (blue) represent low values and the warm colors (red) represent high values. VPR - vascular pulmonary resistance.
Figure 8
Figure 8. Heat plot for pulmonary artery systolic pressure estimated by transthoracic echocardiography and measured by right heart catheterization.
The left sidebar corresponds to the dendrogram generated via an average clustering method with a Euclidean distance measure. PASP - pulmonary artery systolic pressure; RHC - right heart catheterization; TTE - transthoracic echocardiography.

References

    1. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8(8):443–455. - PMC - PubMed
    1. Arvanitaki A, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, et al. Hellenic Society for the Study of Pulmonary Hypertension (HSSPH) Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE) 2045894019877157Pulm Circ. 2019;9(3) - PMC - PubMed
    1. Humbert M, Sitbon O, Yaïci A, Montani D, O'Callaghan DS, Jaïs X, et al. French Pulmonary Arterial Hypertension Network Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36(3):549–555. - PubMed
    1. Howard LS. Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease. Eur Respir Rev. 2011;20(122):236–242. - PMC - PubMed
    1. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation. 2010;122(2):164–172. - PubMed

Publication types